PD11-03 RESPONSE TO APALUTAMIDE (APA) AMONG PATIENTS (PTS) WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) FROM SPARTAN BY DECIPHER GENOMIC CLASSIFIER (GC) SCORE

Fred Saad,Shibu Thomas,Felix Y. Feng,Michael Gormley,Angela Lopez-Gitlitz,Margaret K. Yu,Shinta Cheng,Deborah Ricci,Oliver Brendan Rooney,Paul N. Mainwaring,David Olmos,Simon Chowdhury,Boris Hadaschik,Nick Fishbane,Elai Davicioni,Yang Liu,Eric J. Small,Matthew R. Smith

PD11-03 RESPONSE TO APALUTAMIDE (APA) AMONG PATIENTS (PTS) WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) FROM SPARTAN BY DECIPHER GENOMIC CLASSIFIER (GC) SCORE

2019

Fred Saad
Shibu Thomas
Felix Y. Feng
Michael Gormley
Angela Lopez-Gitlitz
Margaret K. Yu
Shinta Cheng
Deborah Ricci
Oliver Brendan Rooney
Paul N. Mainwaring
David Olmos
Simon Chowdhury
Boris Hadaschik
Nick Fishbane
Elai Davicioni
Yang Liu
Eric J. Small
Matthew R. Smith

INTRODUCTION AND OBJECTIVES:The DECIPHER prostate test (GenomeDx Biosciences, Inc., San Diego, CA) is a clinical-grade mRNA-based test with a genomic classifier (GC) score that has been independent...

Keywords:

Urology
Apalutamide
Oncology
Prostate cancer
Castration
Spartan
DECIPHER
Internal medicine
Medicine
castration resistant
Prostate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations